Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia

Chemerin is dysregulation in numerous solid cancers. However, only little is known about the role of chemerin in acute myeloid leukemia (AML). In this study, we aimed to investigate the expression and clinical significance of recently described chemerin in acute myeloid leukemia (AML). The expressio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Zhang, Jing, Zhou, Jiao, Tang, Xi, Zhou, Ling-Yu, Zhai, Ling-Ling, Vanessa, Minse Evola-Deniz, Yi, Jing, Yi, Yun-Yun, Lin, Jiang, Qian, Jun, Deng, Zhao-Qun
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696201/
https://ncbi.nlm.nih.gov/pubmed/29190935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21440
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares